Can a Team-Based tech approach boost quality of life in older cancer patients?
NCT ID NCT05720910
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new way of organizing care for people aged 70 and older who have cancer (breast, lung, colorectal, or prostate) plus at least one other serious health condition. The GERONTE program brings all their doctors and nurses together using a shared digital care plan. Researchers want to see if this improves patients' quality of life after 6 months compared to usual care. About 720 patients from 8 hospitals in France are taking part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
coordinated care pathway (GERONTE)
What this could lead to
If successful, this could show that a team-based, technology-supported care plan improves quality of life for older adults with cancer and multiple health issues.
What could go wrong
This is a study testing a care process, not a new drug or treatment. It may not show a clear benefit, and results may not apply to all hospitals or patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Azuréen de Cancérologie
Mougins, 06250, France
-
Centre Eugène Marquis
Rennes, 35042, France
-
Centre Hospitalier Départemental Vendée
La Roche-sur-Yon, 85000, France
-
Centre Hospitalier Universitaire de Nice
Nice, 06000, France
-
Centre Hospitalier de la Côte Basque
Bayonne, 64109, France
-
Centre Léon Bérard
Lyon, 69373, France
-
Groupe Hospitalier Rance Emeraude
Dinan, 22100, France
-
Groupe Hospitalier Rance Emeraude
St-Malo, 35400, France
-
Hôpital Tenon AP-HP
Paris, 75020, France
-
Institut Bergonié
Bordeaux, 33076, France